These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1216 related articles for article (PubMed ID: 28412472)
21. In vitro characterization and growth inhibition effect of nanostructured lipid carriers for controlled delivery of methotrexate. Abdelbary G; Haider M Pharm Dev Technol; 2013; 18(5):1159-68. PubMed ID: 21958084 [TBL] [Abstract][Full Text] [Related]
22. Daidzein-loaded nanostructured lipid carriers-PLGA nanofibers for transdermal delivery. Song J; Fan X; Shen Q Int J Pharm; 2016 Mar; 501(1-2):245-52. PubMed ID: 26851353 [TBL] [Abstract][Full Text] [Related]
23. QbD-driven development and evaluation of nanostructured lipid carriers (NLCs) of Olmesartan medoxomil employing multivariate statistical techniques. Beg S; Saini S; Bandopadhyay S; Katare OP; Singh B Drug Dev Ind Pharm; 2018 Mar; 44(3):407-420. PubMed ID: 29048242 [TBL] [Abstract][Full Text] [Related]
24. Histological evaluation of follicular delivery of arginine via nanostructured lipid carriers: a novel potential approach for the treatment of alopecia. Yazdani-Arazi SN; Ghanbarzadeh S; Adibkia K; Kouhsoltani M; Hamishehkar H Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1379-1387. PubMed ID: 27797271 [TBL] [Abstract][Full Text] [Related]
25. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s). Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192 [TBL] [Abstract][Full Text] [Related]
26. Stearic acid grafted chitosan oligosaccharide micelle as a promising vector for gene delivery system: factors affecting the complexation. Du YZ; Lu P; Zhou JP; Yuan H; Hu FQ Int J Pharm; 2010 May; 391(1-2):260-6. PubMed ID: 20170716 [TBL] [Abstract][Full Text] [Related]
27. Shell cross-linked stearic acid grafted chitosan oligosaccharide self-aggregated micelles for controlled release of paclitaxel. Hu FQ; Ren GF; Yuan H; Du YZ; Zeng S Colloids Surf B Biointerfaces; 2006 Jul; 50(2):97-103. PubMed ID: 16759840 [TBL] [Abstract][Full Text] [Related]
28. A Novel Approach for the Development of a Nanostructured Lipid Carrier Formulation by Hot-Melt Extrusion Technology. Bhagurkar AM; Repka MA; Murthy SN J Pharm Sci; 2017 Apr; 106(4):1085-1091. PubMed ID: 28040458 [TBL] [Abstract][Full Text] [Related]
29. Preparation of Chitosan-Coated Nanostructured Lipid Carriers (CH-NLCs) to Control Iron Delivery and Their Potential Application to Food Beverage System. Lee SA; Joung HJ; Park HJ; Shin GH J Food Sci; 2017 Apr; 82(4):904-912. PubMed ID: 28241098 [TBL] [Abstract][Full Text] [Related]
30. Enhanced cellular uptake of chlorine e6 mediated by stearic acid-grafted chitosan oligosaccharide micelles. Hu FQ; Jiang XH; Huang X; Wu XL; Yuan H; Wei XH; Du YZ J Drug Target; 2009 Jun; 17(5):384-91. PubMed ID: 19343607 [TBL] [Abstract][Full Text] [Related]
31. Nanostructured lipid carriers for transdermal delivery of acid labile lansoprazole. Lin WJ; Duh YS Eur J Pharm Biopharm; 2016 Nov; 108():297-303. PubMed ID: 27449633 [TBL] [Abstract][Full Text] [Related]
32. Dutasteride nanocapsules for hair follicle targeting: Effect of chitosan-coating and physical stimulus. Ushirobira CY; Afiune LAF; Pereira MN; Cunha-Filho M; Gelfuso GM; Gratieri T Int J Biol Macromol; 2020 May; 151():56-61. PubMed ID: 32068053 [TBL] [Abstract][Full Text] [Related]
33. Topical phenytoin nanostructured lipid carriers: design and development. Motawea A; Borg T; Abd El-Gawad AEH Drug Dev Ind Pharm; 2018 Jan; 44(1):144-157. PubMed ID: 28956451 [TBL] [Abstract][Full Text] [Related]
34. Ex Vivo and in Vivo Evaluation of the Effect of Coating a Coumarin-6-Labeled Nanostructured Lipid Carrier with Chitosan-N-acetylcysteine on Rabbit Ocular Distribution. Liu D; Li J; Cheng B; Wu Q; Pan H Mol Pharm; 2017 Aug; 14(8):2639-2648. PubMed ID: 28664726 [TBL] [Abstract][Full Text] [Related]
35. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration. Song A; Zhang X; Li Y; Mao X; Han F Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734 [TBL] [Abstract][Full Text] [Related]
36. Impact of nanostructured lipid carriers on dapsone delivery to the skin: in vitro and in vivo studies. Elmowafy M; Shalaby K; Ali HM; Alruwaili NK; Salama A; Ibrahim MF; Akl MA; Ahmed TA Int J Pharm; 2019 Dec; 572():118781. PubMed ID: 31715347 [TBL] [Abstract][Full Text] [Related]
37. Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system. Luo Q; Zhao J; Zhang X; Pan W Int J Pharm; 2011 Jan; 403(1-2):185-91. PubMed ID: 20951778 [TBL] [Abstract][Full Text] [Related]
38. Core-modified chitosan-based polymeric micelles for controlled release of doxorubicin. Ye YQ; Yang FL; Hu FQ; Du YZ; Yuan H; Yu HY Int J Pharm; 2008 Mar; 352(1-2):294-301. PubMed ID: 18096336 [TBL] [Abstract][Full Text] [Related]
39. Preparation and in vitro-in vivo evaluation of ofloxacin loaded ophthalmic nano structured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis. Ustündağ-Okur N; Gökçe EH; Bozbıyık Dİ; Eğrilmez S; Ozer O; Ertan G Eur J Pharm Sci; 2014 Oct; 63():204-15. PubMed ID: 25111119 [TBL] [Abstract][Full Text] [Related]
40. Podophyllotoxin-Loaded Nanostructured Lipid Carriers for Skin Targeting: In Vitro and In Vivo Studies. Zhao J; Piao X; Shi X; Si A; Zhang Y; Feng N Molecules; 2016 Nov; 21(11):. PubMed ID: 27869698 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]